Xuexiao Zhou is an author at Qingdao University specializing in breast cancer, targeted therapy, and tumor biology.
Top concepts
MedicineOncologyImmunologyPharmacologyBreast CancerImmunotherapyTumor BiologyCancer TherapyTargeted Therapy
Publications per year
2021–2022
2
2
Disitamab vedotin: a novel antibody-drug conjugates for cancer therapy
Fan Shi, Yanli Liu, Xuexiao Zhou et al. · Drug Delivery · 2022 · 192 citations · Full text
Her2-targeted Monoclonal Antibody, Drug Targeting, Medicine +13
Rows per page
1–2 of 2